One Amgen Center Drive
Thousand Oaks , CA 91320
Thousand Oaks , CA 91320
News
-
Horizon Therapeutics agreed to be acquired by Amgen for $27.8 billion or $116.50 a share.
Dec 12, 2022
Executive/
Director
Links
Price
- Last Close
-
$ 331
$ -2.59 -0.78 %
Aug 29, 2024
- 52-Week High/Low
- $333.78 - $249.01
- YTD
- 14.9%
- Trading Volume
- 72,069
- Market Cap Full
- $ 177.1B
- Shares Outstanding
-
535.2M
Oct 26, 2023
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 0.9% | -7% | 13% | -1.2% | -2.4% | -5% | 8.2% | 6.9% | -8% | -1.3% |
| Q2 | -3.5% | 2.2% | 5.7% | 12% | -4.1% | 4% | -2% | 0.6% | -8.2% | -2.4% |
| Q3 | -9.5% | 10.3% | 9% | 12.6% | 5.2% | 8% | -12.8% | -8% | 21.1% | - |
| Q4 | 18% | -11.8% | -6.5% | -5.3% | 22.3% | -9.5% | 6.4% | 17.3% | 8.2% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 9.1% | -12.9% | 3.8% | -2.9% | - | - | - | - | - | - | - | - |
| 2023 | -3.9% | -8.2% | 4.4% | -0.8% | -8% | 0.6% | 5.5% | 9.5% | 4.9% | -4.9% | 5.5% | 6.8% |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42% | 4% | -8% | 22% | 15% | 23% | -4% | -2% | 16% | 10% | 15% |
Earnings
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Q1 | 2.48 | 2.90 | 3.15 | 3.25 | 3.18 | 3.07 | 2.83 | 2.68 | 5.28 |
| Q2 | 2.57 | 2.84 | 3.27 | 3.48 | 3.57 | 3.05 | 0.81 | 2.45 | 2.57 |
| Q3 | 2.72 | 3.02 | 3.27 | 2.86 | 3.27 | 3.43 | 3.31 | 3.98 | 3.22 |
| Q4 | 2.61 | 2.89 | 2.89 | 3.03 | 2.85 | 2.76 | 3.36 | 3.00 | - |
| A | 10.4 | 11.7 | 12.6 | 12.6 | 12.9 | 12.3 | 10.3 | 12.1 | 11.07 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Dividend +
Dividend +
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Q1 | 1.45 | 1.60 | 1.76 | 1.94 | 2.13 | 2.25 |
| Q2 | 1.45 | 1.60 | 1.76 | 1.94 | 2.13 | 2.25 |
| Q3 | 1.45 | 1.60 | 1.76 | 1.94 | 2.13 | 2.25 |
| Q4 | 1.45 | 1.60 | 1.76 | 1.94 | 2.13 | 2.25 |
| A | 5.8 | 6.4 | 7.04 | 7.76 | 8.52 | 9 |
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Mar | - | 622.3 | 589.8 | 577.6 | 557 | 534 |
| Jun | 661.7 | 609.9 | 588.2 | 574.6 | 534.2 | 534.3 |
| Sep | 647.3 | 599.7 | 585.7 | 567.9 | 534.9 | 534.9 |
| Dec | 637.2 | 594.2 | 582.2 | 563.3 | 533.6 | 535.2 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | ||||||||||||||||||
| Inventory / Stock Turnover | 1.3 | 1.6 | 1.6 | 1.2 | 1.4 | |||||||||||||
| Fixed Asset Turnover | 2.3 | 2.2 | 2.4 | 3.3 | 3.6 | |||||||||||||
| Total Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | |||||||||||||
| Leverage | ||||||||||||||||||
| Debt Ratio | 1.7 | 1.7 | 1.6 | 1.5 | 0.8 | |||||||||||||
| Debt – Equity Ratio | 10.2 | 5 | 3.5 | 2.8 | 2.4 | |||||||||||||
| Interest Coverage | 3.2 | 4.4 | 4.9 | 5.3 | 5.5 | |||||||||||||
| Equity multiplier | 3.1 | 1.8 | 1.1 | 0.7 | 0.5 | |||||||||||||